key: cord-0910748-1ca0jozs
authors: Novelli, Francesco; Casanova, Jean-Laurent
title: The role of IL-12, IL-23 and IFN-γ in immunity to viruses
date: 2004-04-30
journal: Cytokine Growth Factor Rev
DOI: 10.1016/j.cytogfr.2004.03.009
sha: 6b7ecb2e2e6f95880305565d137d932f6c554511
doc_id: 910748
cord_uid: 1ca0jozs

IL-12, IL-23 and IFN-γ form a loop and have been thought to play a crucial role against infectious viruses, which are the prototype of “intracellular” pathogens. In the last 10 years, the generation of knock-out (KO) mice for genes that control IL-12/IL-23-dependent IFN-γ-dependent mediated immunity (STAT1, IFN-γR1, IFNγR2, IL-12p40 and IL-12Rβ1) and the identification of patients with spontaneous germline mutations in these genes has led to a re-examination of the role of these cytokines in anti-viral immunity. We here review viral infections in mice and humans with genetic defects in the IL-12/IL-23-IFN-γ axis. A comparison of the phenotypes observed in KO mice and deficient patients suggests that the human IL-12/IL-23-IFN-γ axis plays a redundant role in immunity to most viruses, whereas its mouse counterparts play a more important role against several viruses.

Humans with absent (or diminished) response to or impaired production of IFN-␥ caused by nonfunctional or dysfunctional components of IFN-␥ and IL-12/IL-23 signaling [the binding or signaling chains of the IFN-␥ receptor (IFN-␥R1 and IFN-␥R2), the signal transducer and activator of transcription (STAT1), the p40 subunit of IL-12 and IL-23 (IL-12p40), the ␤1 subunit of the IL-12 and IL-23 receptor (IL-12R␤1)] are highly vulnerable to infections due to nontuberculous mycobacteria (NTM) or vaccine-associated bacille Calmette-Guérin (BCG), and to a lesser extent to Salmonella and a few other intracellular bacteria [1] [2] [3] [4] . In contrast, mice whose genes encoding components of the IFN-␥ and IL-12/IL-23 signaling pathways are knock-out (KO) are vulnerable to infection by a broad spectrum of microorganisms, including intracellular bacteria and viruses [5] [6] [7] [8] [9] .

Although viruses are the prototype of "intracellular" parasites, severe viral infection has been reported in only four patients genetically deficient for IFN-␥ receptor [10] [11] [12] . The discrepancies between the clinical phenotypes of patients and of mice deficient for IFN-␥ and IL-12/IL-23 signaling pathway components prompted us to compare the viral susceptibility/resistance of 140 patients with IFN-␥R1 and IFN-␥R2 [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] , STAT1 [32] , IL-12p40 [33] [34] [35] and IL-12R␤1 [4, [36] [37] [38] [39] [40] [41] mutations with the outcome of experimental viral infection in mice deficient for IFN-␥, IFN-␥R1, IL-12p40 or IL-12R␤1, or treated with antibodies neutralizing IFN-␥ or IL-12 so as to provide a clearer picture of the impact of the absence of IFN-␥ and IL-12/IL-23 signaling on viral infection in humans and mice.

Natural infections with "common"(arbitrarily defined as 20-98% of humans seropositive at 10 years) or "rare" (arbitrarily defined as less than 10% seropositive at 10 years) DNA and RNA viruses [42] were considered in patients deficient for IFN-␥-and IL-12/IL-23-mediated immunity. Their Table 1 Common DNA virus infection in the absence of IFN-␥-or IL-12/IL-23-mediated immunity in humans and mice e An apparently normal immune defense refers to a comparable disease or in vitro response between mice with or without impaired IFN␥-or IL-12and IL-23-mediated response.

f An abnormal immune defense refers to a more severe disease or in vitro immune response in mice with impaired IFN␥-or IL-12-and IL-23-mediated response; GKO: IFN-␥ and IFN-␥R1KO mice; aG: anti-IFN␥ antibody-treated mice; 12KO: IL-12p40 and IL-12R␤1 mice; a12: anti-IL-12 antibody-treated mice. Infection routes: intranasal [43, 61, 67, 68, 69] ; corneal [46, [49] [50] [51] 55] ; intradermal [47, 52] ; intraperitoneal [43, 45, 53, [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] 66] . References for each experimental infection are indicated. The genetic backgrounds were: IFN-␥KO mice: Balb/C [46] [47] [48] [49] 57, 65, 66] clinical outcomes were compared with those observed after administration of natural human tropic viruses permissive in mice, or their murine-tropic counterparts, to mice KO for the genes of several components of IL-12/IL-23 signaling (IL-12p40, IL-12R␤1 = 12KO) or IFN-␥ (IFN-␥, IFN-␥R1 = GKO), or treated with neutralizing mAb to IFN-␥ (aG) or IL-12 (a12).

Natural infection with human tropic DNA viruses was considered in deficient patients (Table 1) . No clinical manifestations due to human adenovirus (HAV), human herpes virus 6 (HHV6), parvovirus B19, molluscum contagiosum virus (MCV) and human papilloma virus (HPV) infections were reported (Table 1 ). Many deficient patients displayed positive serology for varicella zoster virus (VZV) and herpes simplex virus (HSV) and only one case of unusually severe clinical form of HSV infection was reported in an IFN-␥R2 deficient patient [10] . Although deficient patients developed a benign form of varicella, two cases of severe clinical form of VZV infections were reported [10, 30] . Epstein Barr virus (EBV) and human herpes virus 8 (HHV8) are associated with lymphoma, nasopharyngeal carcinoma and Kaposi's sarcoma. Positive serology for anti EBV Ig was reported in 71% of deficient patients (Table 1) . Although no clinical cases of EBV infection and mononucleosis or Burkitt lymphoma have been reported, one case of Kaposi's sarcoma occurred in an IFN-␥R1 deficient patient [12] , but no serological data are available. Although deficient patients displayed positive serology for cytomegalovirus (CMV), clinical forms of infections due to CMV were reported in three patients with IFN-␥R1 deficiencies [10, 30] (Table 1) . Thus infections with HHV8 and CMV are those for which IFN-␥, but not IL-12 and IL-23, plays an important role.

Experimental infection with natural murine (and human) tropic DNA viruses in mice with IFN-␥-and IL-12/IL-23-impaired immunity was also considered ( Table 1 ). Immune response was not compromised in the lungs of adenovirus-infected 12KO mice [43] . HSV experimental infection has been extensively described as pathogenic in both GKO [44] [45] [46] [47] [48] [49] [50] [51] and anti-IFN-␥-treated mice [52] [53] [54] , although viral replication of attenuated form of HSV in GKO mice was not different from congenic controls [55] . Experimental infections with murine cytomegalovirus (MCMV), a mouse-permissive (human nontropic) DNA virus, exacerbated infection in GKO [56] [57] [58] , aG [54, 59, 60] , 12KO [61, 62] and a12 [63] mice (Table 1) . However, IFN-␥ is important for resistance to MCMV only, since GKO mice were protected by vaccination with an attenuated MCMV mutant [64] . Wild-type, GKO and aG cleared infectious virus from the lungs 15 days after ␥-herpesvirus 68 (␥-HV68) infection, a specific mouse tropic DNA virus which is a good model for study of ␥-herpesvirus (HHV6 and EBV) pathogenesis [65] . However, GKO mice died weeks to months after ␥-HV68 infection from severe large-vessel arteritis [66] or developed multiorgan fibrosis [67, 68] . Compared with wild-type, ␥-HV68-infected 12KO mice displayed increased lytic and latent virus, and decreased IFN-␥ production, but decreased splenic leukocytosis [69] (Table 1) .

Natural infection with human tropic RNA viruses was considered in deficient patients ( (Table 2 ). By contrast, although positive serology for parainfluenza virus (PIV) and respiratory syncytial virus (RSV) have been reported in deficient patients [70] , clinical manifestations of PIV and RSV infections were reported in only one child with complete IFNGR1 deficiency [10] . While IL-12 and IL-23 do not play a role in infection by common RNA viruses in humans, more patients are needed to confirm that IFN-␥ plays a role in PIV and RSV infection in humans.

Experimental infection with natural mouse (and human) tropic RNA viruses was also considered ( Table 2) . GKO mice [71] [72] [73] [74] as well as anti-IFN-␥ and IL-12 mAb-treated mice [75, 76] are resistant to IV infection (Table 2) . Similarly, GKO mice were resistant to inoculation of rotavirus [77, 78] . After coxackievirus B3 infection, IFN-␥R1KO mice displayed exacerbated virus replication [79] , whereas IFN-␥KO and IL-12KO mice were resistant [79, 80] . After RSV infection, GKO mice as well as anti-IFN-␥ and anti-IL-12 Ab-treated mice displayed more extensive inflammation of the airways than control mice [81] [82] [83] [84] , even if no worsening of pulmonary histopathology was observed in 12KO mice [82, 83] . By contrast, both GKO and anti-IFN-␥ Ab-treated mice became highly susceptible to experimental measles-induced encephalitis [85] [86] [87] . GKO mice displayed no difference with wild-type after infection with myocarditis reovirus 8B, a mouse-permissive (human nontropic) virus [56] (Table 2) . Moreover, autoimmune insulitis and diabetes induced by reovirus infection in mice is reduced and not exacerbated by anti-IFN-␥ and anti-IL-12 antibodies [88, 89] .

Experimental infection with murine-specific tropic RNA viruses was also evaluated in mice with impaired IFN-␥and IL-12/IL-23-mediated immunity ( Table 2 ). After mouse Sendai virus (SV) infection, murine PIV1, IL-12KO, GKO and anti-IFN-␥ mAb-treated mice display little or no difference with wild-type mice [90, 91] and IL-12R␤1KO mice are protected against viral-induced mortality [92] .Compared to control mice, both GKO [93] [94] [95] [96] [97] [98] [99] [100] and anti-IFN-␥ mAb-treated mice [101] , but not 12KO mice [95] , are more susceptible to murine hepatitis virus (MHV) infection, a model for the study of coronavirus infection. In MHV-infected mice the absence of IFN-␥ diminishes demyelination mediated by CD8 T cells [102] and enhances that mediated by CD4 T cells [103] . Interestingly, granulomatous peritonitis and pleuritis occur in GKO mice naturally infected with MHV [100] . Resistant GKO mice display severe encephalomyelitis with extensive primary demyelination and virus persistence following infection with Theiler's murine encephalomyelitis virus (TV) [104, 105] . Administration of neutralizing Ab to IFN-␥, but not to IL-12, increased TV-induced demyelination in susceptible mice and completely abrogated resistance in resistant mice [106] [107] [108] .

Among the rare natural human tropic viruses, only those (or their murine counterparts) tested in mice were considered. Since no infections by vaccinia virus (VV), encephalomyocarditis virus (EMCV), vescicular stomatitis virus (VSV), Semliki Forest virus (SFV), Sindbis virus (SV), equine arteritis virus (EAV), yellow fever (YF), West Nile virus (WNV) and lymphocytic choriomeningitis virus (LCMV) were reported, the vulnerability of deficient patients to these viruses remains unknown ( Table 3 ). The same unknown status was assigned for human immunodeficiency virus (HIV) infection since neither clinical cases nor seropositivity for HIV Ag were reported in deficient patients, even though increased susceptibility to HIV replication of T cells from two IFN-␥R1 and one IL-12R␤1 deficient patient was observed in vitro (Table 3 and [109] ).

Experimental infection of natural rare mouse (and human) tropic viruses was also considered (Table 3) . Although some VV strains express a gene coding for IFN-␥R binding chain which might play a role in virus virulence [110] , IFN-␥KO and anti-IFN-␥ Ab-treated mice succumbed to infection with VV [111, 112] . In IFN-␥KO mice VV clearance was not severely affected, but it was impaired after infection with an attenuated form of VV [113] . GKO mice become more susceptible to WNV infection [114] and can no longer be protected by IL-12 from lethal EMCV infection [115] ( Table 3) . By contrast, wild-type, GKO [112, 116, 117] , 12KO [118] , and anti-IFN-␥ Ab-treated mice [119] were equally infected by VSV, despite the fact that IFN-␥ engineered to be retained in the endoplasmic reticulum mediates in vitro VSV resistance in murine fibroblasts [120] . Following SFV infection 12KO mice showed an enhanced virus replication and pathology in the brain [121] , whereas GKO mice were unaffected [112] . GKO mice were also unaffected following SV [122] and YF [123] infection, even if IFN-␥ mediates T cell-dependent virus clearance from CNS neurons in SV infected-mice [124] . GKO [112, 118, [125] [126] [127] [128] [129] e An apparently normal immune defense refers to a comparable disease or in vitro response between mice with or without impaired IFN␥-or IL-12-mediated response.

f An abnormal immune defense refers to a more severe disease or in vitro immune response in mice with impaired IFN␥-or IL-12/IL-23-mediated response; GKO: and IFN-␥R1KO mice; aG: anti-IFN␥ antibody treated-mice; 12KO: IL-12p40 and IL-12R␤1 KO mice; a12: anti-IL-12 antibody-treated mice. Infection routes: intravenous [112, 117, 126, 131, 142] ; intraperitoneal [113, 114, 125, 126, [139] [140] [141] ; intradermal [112, 125, 135, 136] ; intracerebral [115, 123, 127, 128] ; intranasal [116, 121] ; milk [147] . References for each of the experimental infection are indicated. Genetic backgrounds were: IFN-␥KO mice: Balb/C [112, 125, 127, 128, 141, 149] ; C57BL/6 [114, 116, 117, 123, 127, 128, 145, 147] ; IFN-␥R1KO mice: 129/SV/E [112, 115, 122, 126, [136] [137] [138] [139] [140] ; Balb/C [147] ; anti-IFN␥ antibody-treated mice: Balb/C [113, 132, 142] ; C57BL/6 [112, 119, 135, 143, 144] ; 129/SV/E [113] ; CBA/Ht [140] ; IL-12p40KO mice: C57BL/6 [118, 121, 145] ; anti-IL-12-antibody treated mice: Balb/C [143] . and anti-IFN-␥ Ab-treated [119, 130, 131] mice become more susceptible or succumb to LCMV infection. However, 12KO [118] or anti-IL-12Ab-treated [132] [133] [134] mice infected with LMCV showed comparable viral replication and CTL induction.

Experimental infection with rare murine-specific tropic viruses was considered (Table 3) . GKO and anti-IFN-␥ Ab-treated mice succumbed to infection with mousepox virus, and ecromelia virus (EV) [135, 136] . Inhibition of EV replication is due to the ability of IFN-␥ to induce nitric oxide synthases [137, 138] . By contrast, infection with lactate dehydrogenase (LDV)-elevating virus had no effect in either GKO or anti-IFN-␥ treated mice [139, 140] . Murine AIDS (MAIDS) is induced by LP-BM5 murine leukemia retrovirus (MuLV) in susceptible mice. After LP-BM5 infection, GKO mice displayed accelerated neurodegeneration [141] and the therapeutic effect of IL-12 on mice with MAIDS was absent in GKO and anti-IFN-␥ mAb-treated mice [142] . However, anti-IFN-␥ mAb-treated mice displayed delayed progression of MAIDS [143, 144] and knocking out of IFN-␥ gene or anti-IL-12 mAb treatment did not induce disease in resistant mice [144] . 12KO mice were comparable to wild-type mice in their ability to control murine Friend retrovirus (FV) infection [145] . In contrast, GKO and anti-IFN-␥-treated mice were unable to maintain long-term control over FV infection [146] . No differences between wild-type and GKO mice were observed after mouse mammary tumor virus (MMTV) infection [147] .

Nine years after the discovery of the first germline mutations in IFN-␥-mediated immunity in man [13, 14] an attempt can be made to illustrate the protective impact of the IL-12/IL-23-IFN-␥ axis by comparing the phenotypes of naturally infected deficient patients and experimentally infected deficient mice. Experimental viral infection is conducted with pure, homogeneous laboratory strains, in inbred mice via artificial routes and generally is effective. By contrast, natural infection is the result of incidental exposure to clinical samples of one or more species and is often repelled. It may occur in vaccinated individuals or individuals with a history of other related or unrelated infections [148] . Viral infections in humans are associated with primary immunodeficiency diseases or are idiopathic. In patients with deficiencies in the IFN-␥-and IL-12/IL-23-mediated immunity, viral illness may be favored by previous mycobacterial disease, which results in poor clinical status and low CD4 counts. Several viruses may be associated with resistance in mice, but vulnerability in humans.

Four phenotypes were assigned to deficient patients to define their vulnerability to natural infections: normal (absence of clinical cases, with positive serology or no serological data), moderate (clinical cases, with positive serology or no serological data), high (occurrence of severe or lethal cases with positive serology or no serological data) and unknown (absence of clinical cases reported with no positive serology or no serological data). Three phenotypes were assigned to KO mice to define their vulnerability to experimental viral infection: normal (enhanced morbidity or mortality), moderate (enhanced subclinical infection or enhanced mortality or morbidity in GKO or 12KO mice only), and high (enhanced mortality or morbidity in both GKO and 12KO).

For common DNA viruses, the vulnerability of deficient patients is moderate to HSV and VZV, and high to HCMV and HHV8, whereas that of deficient mice is moderate to ␥-MHV68 and high to HSV and MCMV. In both settings, the IL-12/IL-23-IFN-␥ axis is required for protection against HSV, but not HAV. For natural infections only, it is not required for protection against EBV, HHV6, MCV, B19, and HPV, whereas only IFN-␥ is required for protection against HCMV and HHV8. For experimental infection only, the axis is required for protection against ␥-MHV68.

For common RNA viruses the vulnerability of deficient patients is moderate to PIV and RSV, whereas that of deficient mice is moderate to RSV, MHV and enterovirus and high to measles virus. In both settings, the IL-12/IL-23-IFN-␥ axis is required for protection against RSV, but not IV, rotavirus and enterovirus. For natural infections only, it is required for protection against PIV, but not mumps virus, measles virus, coronavirus, reovirus, HAV and rubella virus. For experimental infections only, it is not required for protection against PIV and reovirus, but it is required for protection against measles virus, coronavirus, and (confined to IFN-␥ only) to enterovirus.

Due to the absence of clinical cases and/or negative serological data, the vulnerability of deficient patients to rare viruses is unknown. For these viruses the vulnerability of deficient mice is moderate to SVF, LCMV, FV and LP-BM5 and high to VV, EV, WNV and EMCV. For experimental infections only, the IL-12/IL-23-IFN-␥ axis is not required for protection against VSV, SV, LDV, YF and MMTV, but is required for protection against VV, EV, WNV and ECMV. IFN-␥ only is required for protection against LMCV and FV whereas IL-12 and IL-23 only are required for protection against SVF.

The vulnerability of natural and experimental infection with rare viruses cannot be compared. The vulnerability of mice to rare viruses and common viruses is much the same (58% versus 54%).

In experimental infections, the IL-12/IL-23 and IFN-␥ axis displays a conspicuous redundancy, since KO mice display vulnerability to about 60% of the rare and common viruses considered. In natural infections, this redundancy is much more pronounced, since deficient patients display modest vulnerability to about 20% of common viruses. This indicates that non-IFN-␥ and non-IL-12/IL-23 mechanisms are certainly involved in the control of viral infections, particularly natural infections.

IL-12 and IL-23 share a common p40 subunit, yet they comprise unique p35 and p19 subunits, respectively [149] . IL-12 and IL-23 receptor complexes share a common IL-12R␤1 subunit, yet they comprise unique IL-12R␤2 and a specific IL-23R component [9] . Since IL-12p40 and IL-12R␤1 mutants, in mice and man, lack both IL-12 and IL-23 immunity [4, 9, 150] , we do not know whether the antiviral effects detected (particularly in natural infections) are caused by the lack of IL-12 or IL-23. A possible unique role of IL-12 in antiviral immunity is suggested by the observation that IL-12p35 KO mice display an enhanced susceptibility following infection with MCMV, SV and VV [61, 90, 113] and that mice deficient in STAT4, which is mainly induced by IL-12 rather than IL-23 [9] , are more susceptible to RSV and VSV infection [84, 151] . However, the simplest explanation for the absence of patients identified as being genetically deficient in p35IL-12-or IL-12R␤2 is the lack of an infectious phenotype, suggesting that IL-12 alone is entirely redundant in protective immunity against all microorganisms in humans.

IFN-␣/␤ is considered to play a major role in antiviral defense [152] . For experimental infections, anti-IFN␣/␤ antibody-treated mice [152] and IFN␣/␤ receptor KO mice [104, 112, [153] [154] [155] [156] [157] , as well as mice deficient in both IFN␣/␤ and IFN-␥ receptors [5, 55] , STAT1 [158, 159] and STAT2 [160] showed marked sensitivity to a broad range of DNA and RNA viruses. However, the IL-12/IL-23 and IFN-␥ axis is interconnected with IFN␣/␤ in the antiviral defense. IL-12 is essential for antibody-mediated protection of HSV-infected mice without a functional IFN type I system [161] and IFN␣/␤ directly activates STAT-4 which is required for IFN-␥ production during viral infection [162] . For natural infection, while patients with a heterozygous STAT1 mutation that impairs IFN-␥, but not IFN␣/␤-mediated activation, are susceptible only to mycobacterial disease [32] , two patients with a heterozygous STAT1 mutation that impairs both IFN-␥ and IFN␣/␤-mediated activation suffered from mycobacterial disease but, unlike patients with IFN-␥R deficiency, died of disseminated HSV-1 infection with recurrent encephalitis [163] . These data indicate that human IFN␣/␤ plays a pivotal role for immunological control of HSV, and probably other viruses in vivo.

Interferon-gamma and interleukin-12 pathway defects and human disease

Genetic dissection of immunity to mycobacteria: the human model

IL-12 and IFN-gamma in host defense against mycobacteria and salmonella in mice and men

Impaired accumulation of and function of memory CD4+ cells in human IL-12 receptor beta1 deficiency

Immune defence in mice lacking type I and/or type II interferon receptors

The role of gamma interferon in antimicrobial immunity

IL-12 and viral infections

The role of IFN-gamma in immune responses to viral infections of the central nervous system

A unique role for IL-23 in promoting cellular immunity

Viral infections in interferon-gamma receptor deficiency

Interferon-gamma receptor deficiency: an expanding clinical phenotype?

HHV8-associated Kaposis's Sarcoma in a child with IFN-␥R1 deficiency

A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection

Interferon-gamma-receptor deficiency in an infant with fatal bacilli Calmette-Guerin infection

Partial interferon-gamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guerin infection and a sibling with clinical tuberculosis

Fatal disseminated Mycobacterium smegmatis infection in a child with inherited interferon gamma receptor deficiency

A causative relationship between mutant IFNgR1 alleles and impaired cellular response to IFNgamma in a compound heterozygous child

Abnormal regulation of interferon-gamma, interleukin-12, and tumor necrosis factor-alpha in human interferongamma receptor 1 deficiency

Familial disseminated infection due to atypical mycobacteria with childhood onset

A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection

Listeria monocytogenes and recurrent mycobacterial infections in a child with complete interferon-gamma-receptor (IFNgammaR1) deficiency: mutational analysis and evaluation of therapeutic options

In a novel form of IFN-gamma receptor 1 deficiency, cell surface receptors fail to bind IFN-gamma

Disseminated bacille Calmette-Guerin infection in an infant with a novel deletion in the interferon-gamma receptor gene

Recurrent Mycobacterium avium osteomyelitis associated with a novel dominant interferon gamma receptor mutation

A point mutation in a domain of gamma interferon receptor 1 provokes severe immunodeficiency

561del4 defines a novel small deletion hotspot in the interferon-gamma receptor 1 chain

Genetic basis of patients with bacille Calmette-Guerin osteomyelitis in Japan: identification of dominant partial interferongamma receptor 1 deficiency as a predominant type

Multifocal osteomyelitis caused by nontuberculous mycobacteria in patients with a genetic defect of the interferongamma receptor

Clinical features of dominant and recessive IFN-␥ receptor 1 deficiencies

Mutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection

Partial interferon-gamma receptor signaling chain deficiency in a patient with bacille Calmette-Guerin and Mycobacterium abscessus infection

Impairment of mycobacterial but not viral immunity by a germline human STAT1 mutation

Inherited interleukin 12 deficiency in a child with bacille Calmette-Guerin and Salmonella enteritidis disseminated infection

Inherited interleukin-12 deficiency: IL12B genotype and clinical phenotype of 13 patients from six hundreds

Clinical and genetic heterogeneity of inherited autosomal recessive susceptibility to disseminated Mycobacterium bovis Bacille Calmette-Guerin infection

Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients

Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency

Missense mutation of the interleukin-12 receptor beta1 chain-encoding gene is associated with impaired immunity against Mycobacterium avium complex infection

Mycobacterium fortuitum-chelonae complex infection in a child with complete interleukin-12 receptor beta 1 deficiency

Interleukin-12 receptor beta1 deficiency in a patient with abdominal tuberculosis

Low penetrance, broad resistence, and favorable outcome of interleukin 12 receptor beta1 deficiency: medical and immunological implications

Fields' virology

IL-12-independent Th1-type immune responses to respiratory viral infection: requirement of IL-18 for IFN-gamma release in the lung but not for the differentiation of viral-reactive Th1-type lymphocytes

IFN-gamma receptor-deficient mice generate antiviral Th1-characteristic cytokine profiles but altered antibody responses

IL-12 stimulates an antiviral type 1 cytokine response but lacks adjuvant activity in IFN-gamma-receptor-deficient mice

Characterization of herpes simplex virus type-1 infection and herpetic stromal keratitis development in IFN-gamma knockout mice

Role of interferon-gamma in immunity to herpes simplex virus

Interferon-gamma protects against herpes simplex virus type 1-mediated neuronal death

Clarke KGamma interferon (IFN-gamma) receptor null-mutant mice are more susceptible to herpes simplex virus type 1 infection than IFN-gamma ligand null-mutant mice

Cantin E Gender influences herpes simplex virus type 1 infection in normal and gamma interferon-mutant mice

Role for gamma interferon in control of herpes simplex virus type 1 reactivation

IFN-gamma and IL-2 are protective in the skin but pathologic in the corneas of HSV-1-infected mice

Control of acute cutaneous herpes simplex virus infection: T cell-mediated viral clearance is dependent upon interferon-gamma (IFN-gamma)

The T-cell-independent role of gamma interferon and tumor necrosis factor alpha in macrophage activation during murine cytomegalovirus and herpes simplex virus infections

Interferons regulate the phenotype of wild-type and mutant herpes simplex viruses in vivo

Interferon gamma regulates acute and latent murine cytomegalovirus infection and chronic disease of the great vessels

Role of interferon-gamma in murine cytomegalovirus infection

Biologic consequences of Stat1-independent IFN signaling

Gamma interferon-dependent clearance of cytomegalovirus infection in salivary glands

Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration

The role of endogenous interleukin-12 in resistance to murine cytomegalovirus (MCMV) infection and a novel action for endogenous IL-12 p40

Cutting edge: selective IL-18 requirements for induction of compartmental IFNgamma responses during viral infection

Characterization of early IL-12, IFNalphabeta, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection

Virgin IV HW. Mucosal and parental vaccination against acute and latent murine cytomegalovirus (MCMV) infection by using an attenuated MCMV mutant

Gamma interferon is not essential for recovery from acute infection with murine gammaherpesvirus 68

Murine gamma-herpesvirus 68 causes severe large-vessel arteritis in mice lacking interferon-gamma responsiveness: a new model for virus-induced vascular disease

Pathological changes in the spleens of gamma interferon receptor-deficient mice infected with murine gammaherpesvirus: a role for CD8 T cells

Murine gammaherpesvirus-68 infection causes multi-organ fibrosis and alters leukocyte trafficking in interferon-gamma receptor knockout mice

Murine gamma-herpesvirus-68-induced IL-12 contributes to the control of latent viral burden, but also contributes to viral-mediated leukocytosis

Response to influenza infection in mice with a targeted disruption in the interferon gamma gene

Protective role of gamma interferon during the recall response to influenza virus

The role of alpha/beta and gamma interferons in development of immunity to influenza A virus in mice

Gamma interferon is not required for mucosal cytotoxic T-lymphocyte responses or heterosubtypic immunity to influenza A virus infection in mice

In vivo blockade of gamma interferon affects the influenza virus-induced humoral and the local cellular immune response in lung tissue

Role of interleukin-12 in primary influenza virus infection

Evidence for CD8+ T-cell immunity to murine rotavirus in the absence of perforin, fas, and gamma interferon

Lack of a role for type I and type II interferons in the resolution of rotavirusinduced diarrhea and infection in mice

IL-12 receptor beta 1 and Toll-like receptor 4 increase IL-1 beta-and IL-18-associated myocarditis and coxsackievirus replication

Cardioselective infection with coxsackievirus B3 requires intact type I interferon signaling: implications for mortality and early viral replicatoion

The role of interferon gamma in the pathogenesis of primary respiratory syncytial virus infection in BALB/c mice

Effect of lack of interleukin-4, interleukin-12, interleukin-18, or the interferon-gamma receptor on virus replication, cytokine response, and lung pathology during respiratory syncytial virus infection in mice

Respiratory syncytial virus enhances respiratory allergy in mice despite the inhibitory effect of virus-induced interferon-gamma

Role of interleukin-12 and stat-4 in the regulation of airway inflammation and hyperreactivity in respiratory syncytial virus infection

Gamma interferon is a major mediator of antiviral defense in experimental measles virus-induced encephalitis

Immunemediated protection from measles virus-induced central nervous system disease is noncytolytic and gamma interferon dependent

Inhibition of major histocompatibility complex class II-dependent antigen presentation by neutralization of gamma interferon leads to breakdown or resistance against measles virus-induced encephalitis

Interferon-gamma plays a role in pancreatic islet-cell destruction of reovirus type 2-induced diabetes-like syndrome in DBA/1 suckling mice

Possible involvement of IL-12 in reovirus type-2-induced diabetes in newborn DBA/1 mice

Interleukin 12p40 production by barrier epithelial cells during airway inflammation

The cytotoxic Tlymphocyte response to Sendai virus is unimpaired in the absence of gamma interferon

IL-12 p40 homodimer-dependent macrophage chemotaxis and respiratory viral inflammation are mediated through IL-12 receptor beta1

Exacerbated viral hepatitis in IFN-gamma receptor-deficient mice is not suppressed by IL-12

Disassociation between the in vitro and in vivo effects of nitric oxide on a neurotropic murine coronavirus

Mice lacking IL-12 develop polarized Th1 cells during viral infection

Murine coronavirus-induced subacute fatal peritonitis in C57BL/6 mice deficient in gamma interferon

MHV-induced fatal peritonitis in mice lacking IFN-gamma

Murine coronavirus-induced subacute fatal peritonitis in C57BL/6 mice deficient in gamma interferon

IFN-gamma is required for viral clearance from central nervous system oligodendroglia

Granulomatous peritonitis and pleuritis in interferon-gamma gene knockout mice naturally infected with mouse hepatitis virus

In vivo depletion of interferon-gamma leads to susceptibility of A/J mice to mouse hepatitis virus 3 infection

Cutting edge: CD8 T cell-mediated demyelination is IFN-gamma dependent in mice infected with a neurotropic coronavirus

CD4 T-cell-mediated demyelination is increased in the absence of gamma interferon in mice infected with mouse hepatitis virus

Theiler's virus infection of 129Sv mice that lack the interferon alpha/beta or interferon gamma receptors

Pease prevalent class I-restricted T-cell response to the Theiler's virus epitope Db:VP2121-130 in the absence of endogenous CD4 help, tumor necrosis factor alpha, gamma interferon, perforin, or costimulation through CD28

Suppressive effect on Theiler's murine encephalomyelitis virus-induced demyelinating disease by the administration of anti-IL-12 antibody

Gamma interferon is critical for resistance to Theiler's virus-induced demyelination

Alteration in the level of interferon-gamma results in acceleration of Theiler's virus-induced demyelinating disease

IFN-gamma and IL-12 differentially regulate CC-chemokine secretion and CCR5 expression in human T lymphocytes

Effect of IFN-gamma receptor gene deletion on vaccinia virus virulence

The antiviral activity of immune CD8+ T cells is dependent on interferon-gamma

Functional role of type I and type II interferons in antiviral defense

KopfM IL-4 and IL-10 antagonize IL-12-mediated protection against acute vaccinia virus infection with a limited role of IFN-gamma and nitric oxide synthetase 2

IFNgamma-producing gammadelta T cells help control murine West Nile virus infection

The in vivo antiviral activity of interleukin-12 is mediated by gamma interferon

IFN-gamma is not required in the IL-12 response to vesicular stomatitis virus infection of the olfactory bulb

CD4(+) T cell-mediated protection against a lethal outcome of systemic infection with vesicular stomatitis virus requires CD40 ligand expression, but not IFN-gamma or IL-4

IL-12 is not required for induction of type 1 cytokine responses in viral infections

Enhanced virus replication and inhibition of lymphocytic choriomeningitis virus disease in anti-gamma interferon-treated mice

Intracellular murine IFN-gamma mediates virus resistance, expression ofoligoadenylate synthetase, and activation of STAT transcription factors

Avirulent Semliki Forest virus replication and pathology in the central nervous system is enhanced in IL-12-defective and reduced in IL-4-defective mice: a role for Th1 cells in the protective immunity

Biologic consequences of Stat1-independent IFN signaling

Yellow fever virus encephalitis: properties of the brain-associated T-cell response during virus clearance in normal and gamma interferon-deficient mice and requirement for CD4+ lymphocytes

Interferon-gamma-mediated site-specific clearance of alphavirus from CNS neurons

An essential role for type 1 interferon-gamma in terminating persistent viral infection

Apoptotic regulation of T cells and absence of immune deficiency in virus-infected gamma interferon receptor knockout mice

Role of interferon-gamma in the pathogenesis of LCMV-induced meningitis: unimpaired leucocyte recruitment, but deficient macrophage activation in interferon-gamma knock-out mice

Compromised virus control and augmented perforin-mediated immunopathology in IFN-gamma-deficient mice infected with lymphocytic choriomeningitis virus

Critical role for alpha/beta and gamma interferons in persistence of lymphocytic choriomeningitis virus by clonal exhaustion of cytotoxic T cells

Mechanism of recovery from acute virus infection. VIII. Treatment of lymphocytic choriomeningitis virus-infected mice with anti-interferon-gamma monoclonal antibody blocks generation of virus-specific cytotoxic T lymphocytes and virus elimination

Modulation by gamma interferon of antiviral cell-mediated immune responses in vivo

IL12 in acute viral infectious disease

An absolute and restricted requirement for IL-12 in natural killer cell IFN-gamma production and antiviral defense. Studies of natural killer and T cell responses in contrasting viral infections

Interleukin-12 in infectious diseases

Importance of interferons in recovery from mousepox

Cytokines and immunity to viral infections

Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase

Identification of nitric oxide synthase 2 as an innate resistance locus against ectromelia virus infection

Regulation of immune complexes during infection of mice with lactate dehydrogenaseelevating virus: studies with interferon-gamma gene knockout and tolerant mice

IFN-gamma-independent IgG2a

production in mice infected with viruses and parasites

Accelerated development of neurochemical and behavioral deficits in LP-BM5 infected mice with targeted deletions of the IFN-gamma gene

In vivo treatment with interleukin 12 protects mice from immune abnormalities observed during murine acquired immunodeficiency syndrome (MAIDS)

An IFN-gamma-dependent pathway plays a critical role in the pathogenesis of murine immunodeficiency syndrome induced by LP-BM5 murine leukemia virus

Role of IL12 in MAIDS

Role of interleukin-4 (IL-4), IL-12, and gamma interferon in primary and vaccine-primed immune responses to Friend retrovirus infection

CD4(+) T cells and gamma interferon in the long-term control of persistent friend retrovirus infection

Immune response to mouse mammary tumor virus in mice lacking the alpha/beta interferon or the gamma interferon receptor

The human model: a genetic dissection of immunity to infection in natural conditions

Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12

Retroviral-mediated gene transfer restores the IL-12 and IL-23 signaling pathway in T Cells from IL-12 receptor ␤1 deficient patients

IL-12, while beneficial, is not essential for the host response to VSV encephalitis

Wherefore interferon?

Role of interferon and interferon regulatory factors in early protection against Venezuelan equine encephalitis virus infection

Control of Sindbis virus infection by antibody in interferon-deficient mice

The role of interferon in influenza virus tissue tropism

Antiviral protection by vesicular stomatitis virusspecific antibodies in alpha/beta interferon receptor-deficient mice

Human MxA protein protects mice lacking a functional alpha/beta interferon system against La crosse virus and other lethal viral infections

Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease

Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway

Immune response in Stat2 knockout mice

Interleukin-12-and gamma interferon-dependent innate immunity are essential and sufficient for long-term survival of passively immunized mice infected with herpes simplex virus type 1

Critical role for STAT4 activation by type 1 interferons in the interferon-gamma response to viral infection

Impaired response to interferon ␣/␤ and lethal viral disease in human STAT deficiency